Article info
PDFReview
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
- Correspondence to Dr Bo Zhu; bo.zhu{at}tmmu.edu.cn; Dr Huoming Chen; chenhuoming_onco{at}163.com; Dr Zhaoxia Li; lizhaoxia_onco{at}163.com
Citation
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
Publication history
- Accepted January 12, 2021
- First published February 16, 2021.
Online issue publication
January 26, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.